Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy [Phase 3]
A Phase 3 trial evaluating toremifene citrate to prevent bone fractures in men with prostate cancer on androgen deprivation therapy has comp…
-
CLINICAL_TRIALS withdrawal · 2013-11-15Clinical Trial Update: Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer [Phase 3]
A Phase 3 trial evaluating toremifene citrate to reduce the risk of new bone fractures in men with prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer [Phase 1]
The document reports the completion of an extended Phase 1 study of a prostate-specific membrane antigen antibody-drug conjugate in patients…
-
CLINICAL_TRIALS research · 2013-11-14Clinical Trial Update: Pilot Study on Focal Prostate Radio-Frequency Ablation [NA]
Update on a completed pilot clinical trial evaluating focal prostate radio-frequency ablation for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer [Phase 1]
This is a Phase 1 clinical trial evaluating the safety and feasibility of combining Samarium-153 with neoadjuvant hormonal therapy and radia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-11-08Clinical Trial Update: Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
The observational longitudinal study of pain in men with metastatic castration-resistant prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer [Phase 3]
This report updates a Phase 3 trial evaluating ultrasound-based treatment for recurrent stage I/II prostate cancer, which has been terminate…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: 3-AP in Treating Patients With Advanced Prostate Cancer [Phase 2]
A Phase 2 trial evaluating 3-AP (Triapine) for advanced prostate cancer conducted by Vion Pharmaceuticals has completed.
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Phase 2]
A Phase 2 clinical trial update evaluating the combination of Bevacizumab with hormone therapy and radiation therapy for locally advanced pr…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer [Phase 3]
This entry reports the completion of a Phase 3 clinical trial evaluating proton radiation therapy for stage I or stage II prostate cancer.
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Brachytherapy in Treating Patients With Recurrent Prostate Cancer [Phase 1, Phase 2]
An update on an ongoing brachytherapy clinical trial for recurrent prostate cancer in Phase 1/Phase 2. The sponsor is the Center for Molecul…
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA) [Phase 3]
Phase 3 trial evaluating androgen deprivation with leuprolide with or without docetaxel in clinically asymptomatic prostate cancer patients …
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma [Phase 2]
Phase 2 observational study of continuous oral dosing of Abiraterone Acetate in castration-resistant prostate cancer, evaluating androgen an…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer [Phase 1]
Phase 1 study of a prostate-specific membrane antigen antibody-drug conjugate in men with prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer [Phase 2]
Phase 2 neoadjuvant study of weekly ixabepilone in high-risk, localized prostate cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy [Phase 4]
A Phase 4 clinical trial by GlaxoSmithKline evaluating a prostate cancer treatment in men who failed first-line androgen deprivation therapy…
-
CLINICAL_TRIALS withdrawal · 2013-10-28Clinical Trial Update: Exercise Training Among Men With Prostate Cancer [NA]
A Duke University-sponsored trial evaluating exercise training for men with prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide [Phase 1]
Phase 1 trial evaluating EMD 273066 in EpCAM-positive recurrent ovarian, prostate, colorectal, or non-small cell lung cancer when first trea…
-
CLINICAL_TRIALS withdrawal · 2013-10-24Clinical Trial Update: Gene Therapy for Prostate Cancer That Returns After Radiation Therapy [Phase 1]
A Phase 1 gene therapy trial for prostate cancer that recurs after radiation therapy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer [NA]
A study evaluating zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for prostate cancer has completed. The…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer [Phase 2]
This update reports the results of a Phase 2 trial of erlotinib as a single agent in chemotherapy-naive androgen-independent (castration-res…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis. [NA]
This update reports on a completed clinical trial evaluating the use of multi-parametric MRI with prostate biopsy to improve diagnosis of pr…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer [NA]
This clinical trial update notes the completion of a study evaluating the impact of androgen suppression on bone loss in men with prostate c…
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer [Phase 3]
An extension study assessing the long-term safety of denosumab in patients undergoing androgen deprivation therapy for non-metastatic prosta…
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Sulforadex in Healthy Volunteers SAD [Phase 1]
Phase 1 single-ascending-dose study of Sulforadex in healthy volunteers has completed; the trial lists stage prostate cancer as the conditio…